Irvine, California Clinical Trials

A listing of Irvine, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

To evaluate the safety and tolerability of AMG 910 in adult subjects, and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D)

Research Site
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

SARS
acute respiratory syndrome (sars)
oximetry
covid-19
pneumonia
Research Site
 (7.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

heart disease
sickle cell anemia
cough
cardiovascular disease
dyspnea
University of CA, Irvine
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.

structured clinical interview
major depressive disorder
psychiatric disorder
psychotherapy
depression
Sage Investigational Site
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +35 other locations
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)

This is a multicenter, multinational, open-label, one-way cross-over, Phase 3, single-arm study for treatment of hemophilia. The purpose of this study is to measure the frequency of treated bleeding episodes with fitusiran in male adult and adolescent (≥12 years old) participants with hemophilia A or B, with or without inhibitory …

Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
 (7.5 away) Contact site
  • 0 views
  • 24 May, 2024
  • +53 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
dulaglutide
tirzepatide
body mass index
Diabetes Associates Medical Group
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
mini-mental state examination
flortaucipir
positron emission tomography
alzheimer's disease
Irvine Clinical Research Center
 (0.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +85 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

combination therapy
acute respiratory syndrome (sars)
intrauterine device (iud)
critical illness
dexamethasone
Coronavirus Research Institute
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

bethesda assay
factor ix
antihemophilic factor
fitusiran
hemophilia
Investigational Site Number 8400010
 (7.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX

Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: To characterize the long-term efficacy of fitusiran as assessed by the frequency of: Bleeding episodes Spontaneous bleeding episodes Target joint bleeding episodes To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants …

hemarthrosis
fitusiran
antihemophilic factor
hemophilia
haemophilia a
Investigational Site Number 8400016
 (7.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +40 other locations